KYOTO, Japan and SYDNEY, Australia, 22 July 2004 - Shimadzu Biotech, a global business unit of Shimadzu Corporation, and Proteome Systems today announced that their jointly developed Chemical InkJet Printer (CHIP 1000) has been selected as one of the 100 most technologically significant products introduced into the marketplace over the past year. The R&D 100 award was bestowed by the independent judging panel and editors of R&D Magazine, in what was highlighted as a very competitive year of nominations. The novel ChIP technology offers researchers a revolutionary new approach to automatic protein processing, identification and characterization. Developed jointly by Shimadzu Biotech and Proteome Systems, with financial support from the Australian Government’s START Program, the ChIP is a unique technology platform for executing micro-scale on-membrane chemistry that will have widespread applications in biomedical research and biomarker discovery.
